{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:56:37Z","timestamp":1793325397787,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR5RA902"],"award-info":[{"award-number":["22JR5RA902"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5) plays an important role in a variety of physiological or pathological processes, including in cancers. However, the biological roles of ARL6IP5 in cancers are controversial. In this mini-review, we summarized the current understanding on the role of ARL6IP5 in cancers, particularly in the progression of chronic hepatitis virus-related hepatocellular carcinoma, as well as the potential values of ARL6IP5 in cancer therapy.<\/jats:p>","DOI":"10.1038\/s41417-025-00903-x","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:03:17Z","timestamp":1745064197000},"page":"744-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ARL6IP5 in cancers: bidirectional function and therapeutic value"],"prefix":"10.1038","volume":"32","author":[{"given":"Zenan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4310-7000","authenticated-orcid":false,"given":"Hanxun","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-8935","authenticated-orcid":false,"given":"Liang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"903_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9:217\u201322.","journal-title":"J Epidemiol Glob Health"},{"key":"903_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomark Prev. 2016;25:16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"903_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"903_CR4","unstructured":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736-88."},{"key":"903_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8:420\u201344.","journal-title":"JAMA Oncol"},{"key":"903_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2007","unstructured":"Wood LD, Parsons DW, Jones S, Lin J, Sj\u00f6blom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108\u201313.","journal-title":"Science"},{"key":"903_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol. 2020;17:457\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"903_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012\u201327.","journal-title":"Trends Genet"},{"key":"903_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"903_CR10","unstructured":"Zhou J. A novel cytoskeleton associate gene-cloning, identification, sequencing, regulation of expression and tissue distribution of JWA. Beijing: Military Medical Sciences Press; 1999."},{"key":"903_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gene.2005.12.009","volume":"371","author":"CS Fo","year":"2006","unstructured":"Fo CS, Coleman CS, Wallick CJ, Vine AL, Bachmann AS. Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2). Gene. 2006;371:154\u201365.","journal-title":"Gene"},{"key":"903_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neulet.2007.08.056","volume":"426","author":"S Akiduki","year":"2007","unstructured":"Akiduki S, Ochiishi T, Ikemoto MJ. Neural localization of addicsin in mouse brain. Neurosci Lett. 2007;426:149\u201354.","journal-title":"Neurosci Lett"},{"key":"903_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1124\/mol.107.039461","volume":"72","author":"M Watabe","year":"2007","unstructured":"Watabe M, Aoyama K, Nakaki T. Regulation of glutathione synthesis via interaction between glutamate transport-associated protein 3-18 (GTRAP3-18) and excitatory amino acid carrier-1 (EAAC1) at plasma membrane. Mol Pharm. 2007;72:1103\u201310.","journal-title":"Mol Pharm"},{"key":"903_CR14","doi-asserted-by":"publisher","first-page":"31323","DOI":"10.1074\/jbc.M801570200","volume":"283","author":"S Akiduki","year":"2008","unstructured":"Akiduki S, Ikemoto MJ. Modulation of the neural glutamate transporter EAAC1 by the addicsin-interacting protein ARL6IP1. J Biol Chem. 2008;283:31323\u201332.","journal-title":"J Biol Chem"},{"key":"903_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2005.06.013","volume":"386","author":"K Inoue","year":"2005","unstructured":"Inoue K, Akiduki S, Ikemoto MJ. Expression profile of addicsin\/GTRAP3-18 mRNA in mouse brain. Neurosci Lett. 2005;386:184\u20138.","journal-title":"Neurosci Lett"},{"key":"903_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3233\/JAD-220391","volume":"90","author":"AE Weller","year":"2022","unstructured":"Weller AE, Ferraro TN, Doyle GA, Reiner BC, Crist RC, Berrettini WH. Single Nucleus Transcriptome Data from Alzheimer\u2019s Disease Mouse Models Yield New Insight into Pathophysiology. J Alzheimers Dis. 2022;90:1233\u201347.","journal-title":"J Alzheimers Dis"},{"key":"903_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35065084","volume":"410","author":"CI Lin","year":"2001","unstructured":"Lin CI, Orlov I, Ruggiero AM, Dykes-Hoberg M, Lee A, Jackson M, et al. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature. 2001;410:84\u20138.","journal-title":"Nature"},{"key":"903_CR18","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/00001756-200211150-00018","volume":"13","author":"MJ Ikemoto","year":"2002","unstructured":"Ikemoto MJ, Inoue K, Akiduki S, Osugi T, Imamura T, Ishida N, et al. Identification of addicsin\/GTRAP3-18 as a chronic morphine-augmented gene in amygdala. Neuroreport. 2002;13:2079\u201384.","journal-title":"Neuroreport"},{"key":"903_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0378-1119(02)00669-8","volume":"292","author":"ME Butchbach","year":"2002","unstructured":"Butchbach ME, Lai L, Lin CL. Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene. 2002;292:81\u201390.","journal-title":"Gene"},{"key":"903_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1471-4159.2003.01588.x","volume":"84","author":"ME Butchbach","year":"2003","unstructured":"Butchbach ME, Guo H, Lin CL. Methyl-beta-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. J Neurochem. 2003;84:891\u20134.","journal-title":"J Neurochem"},{"key":"903_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/15287390590903711","volume":"68","author":"R Chen","year":"2005","unstructured":"Chen R, Li A, Zhu T, Li C, Liu Q, Chang HC, et al. JWA-a novel environmental-responsive gene, involved in estrogen receptor-associated signal pathway in MCF-7 and MDA-MB-231 breast carcinoma cells. J Toxicol Environ Health A. 2005;68:445\u201356.","journal-title":"J Toxicol Environ Health A"},{"key":"903_CR22","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.3390\/ijms241310499","volume":"24","author":"I Siddique","year":"2023","unstructured":"Siddique I, Kamble K, Gupta S, Solanki K, Bhola S, Ahsan N, et al. ARL6IP5 Ameliorates \u03b1-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12. Int J Mol Sci. 2023;24:10499.","journal-title":"Int J Mol Sci"},{"key":"903_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/mc.21981","volume":"53","author":"X Wu","year":"2014","unstructured":"Wu X, Chen H, Gao Q, Bai J, Wang X, Zhou J, et al. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Mol Carcinog. 2014;53:325\u201336.","journal-title":"Mol Carcinog"},{"key":"903_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep11009","volume":"5","author":"Y Li","year":"2015","unstructured":"Li Y, Shen X, Wang X, Li A, Wang P, Jiang P, et al. EGCG regulates the cross-talk between JWA and topoisomerase II\u03b1 in non-small-cell lung cancer (NSCLC) cells. Sci Rep. 2015;5:11009.","journal-title":"Sci Rep"},{"key":"903_CR25","doi-asserted-by":"publisher","first-page":"e52348","DOI":"10.1371\/journal.pone.0052348","volume":"7","author":"X Liu","year":"2012","unstructured":"Liu X, Wang S, Xia X, Chen Y, Zhou Y, Wu X, et al. Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer. PLoS One. 2012;7:e52348.","journal-title":"PLoS One"},{"key":"903_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/cas.12111","volume":"104","author":"Y Ye","year":"2013","unstructured":"Ye Y, Li X, Yang J, Miao S, Wang S, Chen Y, et al. MDM2 is a useful prognostic biomarker for resectable gastric cancer. Cancer Sci. 2013;104:590\u20138.","journal-title":"Cancer Sci"},{"key":"903_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/carcin\/bgt311","volume":"35","author":"Y Chen","year":"2014","unstructured":"Chen Y, Huang Y, Huang Y, Xia X, Zhang J, Zhou Y, et al. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer. Carcinogenesis. 2014;35:442\u201351.","journal-title":"Carcinogenesis"},{"key":"903_CR28","first-page":"3120","volume":"13","author":"W Wang","year":"2020","unstructured":"Wang W, Yang J, Yu Y, Deng J, Zhang H, Yao Q, et al. Expression of JWA and XRCC1 as prognostic markers for gastric cancer recurrence. Int J Clin Exp Pathol. 2020;13:3120\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"903_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cellsig.2007.01.007","volume":"19","author":"H Chen","year":"2007","unstructured":"Chen H, Bai J, Ye J, Liu Z, Chen R, Mao W, et al. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal. 2007;19:1315\u201327.","journal-title":"Cell Signal"},{"key":"903_CR30","first-page":"8137","volume":"17","author":"L Xu","year":"2018","unstructured":"Xu L, Cheng L, Yang F, Pei B, Liu X, Zhou J, et al. JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4. Mol Med Rep. 2018;17:8137\u201344.","journal-title":"Mol Med Rep"},{"key":"903_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1440-1681.2006.04446.x","volume":"33","author":"WG Mao","year":"2006","unstructured":"Mao WG, Liu ZL, Chen R, Li AP, Zhou JW. JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in Hela cells. Clin Exp Pharm Physiol. 2006;33:816\u201324.","journal-title":"Clin Exp Pharm Physiol"},{"key":"903_CR32","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/carcin\/bgt318","volume":"34","author":"J Lu","year":"2013","unstructured":"Lu J, Tang Y, Farshidpour M, Cheng Y, Zhang G, Jafarnejad SM, et al. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma. Carcinogenesis. 2013;34:2778\u201388.","journal-title":"Carcinogenesis"},{"key":"903_CR33","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/bjc.2013.670","volume":"109","author":"J Lu","year":"2013","unstructured":"Lu J, Tang Y, Cheng Y, Zhang G, Yip A, Martinka M, et al. ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients. Br J Cancer. 2013;109:2842\u201352.","journal-title":"Br J Cancer"},{"key":"903_CR34","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3892\/etm.2014.1650","volume":"7","author":"J Lin","year":"2014","unstructured":"Lin J, Ma T, Jiang X, Ge Z, Ding W, Wu Y, et al. JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways. Exp Ther Med. 2014;7:1767\u201371.","journal-title":"Exp Ther Med"},{"key":"903_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-476","volume":"10","author":"TL Romanuik","year":"2009","unstructured":"Romanuik TL, Wang G, Holt RA, Jones SJ, Marra MA, Sadar MD. Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries. BMC Genomics. 2009;10:476.","journal-title":"BMC Genomics"},{"key":"903_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1593\/tlo.09166","volume":"3","author":"IW Cunha","year":"2010","unstructured":"Cunha IW, Carvalho KC, Martins WK, Marques SM, Muto NH, Falzoni R, et al. Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol. 2010;3:23\u201332.","journal-title":"Transl Oncol"},{"key":"903_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/15287390701285824","volume":"70","author":"CP Li","year":"2007","unstructured":"Li CP, Zhu YJ, Chen R, Wu W, Li AP, Liu J, et al. Functional polymorphisms of JWA gene are associated with risk of bladder cancer. J Toxicol Environ Health A. 2007;70:876\u201384.","journal-title":"J Toxicol Environ Health A"},{"key":"903_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.leukres.2006.09.009","volume":"31","author":"Q Shen","year":"2007","unstructured":"Shen Q, Tang WY, Li CP, Chen R, Zhu YJ, Huang S, et al. Functional variations in the JWA gene are associated with increased odds of leukemias. Leuk Res. 2007;31:783\u201390.","journal-title":"Leuk Res"},{"key":"903_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1200\/JCO.2012.44.3184","volume":"31","author":"Z Li","year":"2013","unstructured":"Li Z, Herold T, He C, Valk PJ, Chen P, Jurinovic V, et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol. 2013;31:1172\u201381.","journal-title":"J Clin Oncol"},{"key":"903_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","volume":"182","author":"N Walther","year":"2013","unstructured":"Walther N, Ulrich A, Vockerodt M, von Bonin F, Klapper W, Meyer K, et al. Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt\u2019s lymphoma. Am J Pathol. 2013;182:1092\u20138.","journal-title":"Am J Pathol"},{"key":"903_CR41","first-page":"804","volume":"13","author":"Q Shen","year":"2005","unstructured":"Shen Q, Zhou JW, Sheng RL, Zhu GR, Cao HX, Lu H. JWA gene in regulating committed differentiation of HL-60 cells induced by ATRA, Ara-C and TPA]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005;13:804\u20138.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"903_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11373-005-9068-0","volume":"13","author":"S Huang","year":"2006","unstructured":"Huang S, Shen Q, Mao WG, Li AP, Ye J, Liu QZ, et al. JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci. 2006;13:357\u201371.","journal-title":"J Biomed Sci"},{"key":"903_CR43","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1074\/jbc.M701008200","volume":"283","author":"AM Ruggiero","year":"2008","unstructured":"Ruggiero AM, Liu Y, Vidensky S, Maier S, Jung E, Farhan H, et al. The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b\/GTRAP3-18 protein. J Biol Chem. 2008;283:6175\u201383.","journal-title":"J Biol Chem"},{"key":"903_CR44","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1523\/JNEUROSCI.3351-08.2008","volume":"28","author":"M Watabe","year":"2008","unstructured":"Watabe M, Aoyama K, Nakaki T. A dominant role of GTRAP3-18 in neuronal glutathione synthesis. J Neurosci. 2008;28:9404\u201313.","journal-title":"J Neurosci"},{"key":"903_CR45","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.yexcr.2008.01.028","volume":"314","author":"GL Wang","year":"2008","unstructured":"Wang GL, Shi X, Salisbury E, Timchenko NA. Regulation of apoptotic and growth inhibitory activities of C\/EBPalpha in different cell lines. Exp Cell Res. 2008;314:1626\u201339.","journal-title":"Exp Cell Res"},{"key":"903_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1582-4934.2008.00303.x","volume":"13","author":"S Maier","year":"2009","unstructured":"Maier S, Reiterer V, Ruggiero AM, Rothstein JD, Thomas S, Dahm R, et al. GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation. J Cell Mol Med. 2009;13:114\u201324.","journal-title":"J Cell Mol Med"},{"key":"903_CR47","first-page":"212","volume":"21","author":"NP Wang","year":"2003","unstructured":"Wang NP, Zhou JW, Li AP, Cao HX, Wang XR. The mechanism of JWA gene involved in oxidative stress of cells]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2003;21:212\u20135.","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"903_CR48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1080\/15287390500360612","volume":"69","author":"T Zhu","year":"2006","unstructured":"Zhu T, Chen R, Li A, Liu J, Gu D, Liu Q, et al. JWA as a novel molecule involved in oxidative stress-associated signal pathway in myelogenous leukemia cells. J Toxicol Environ Health A. 2006;69:1399\u2013411.","journal-title":"J Toxicol Environ Health A"},{"key":"903_CR49","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.freeradbiomed.2007.02.018","volume":"42","author":"R Chen","year":"2007","unstructured":"Chen R, Qiu W, Liu Z, Cao X, Zhu T, Li A, et al. Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]pyrene and hydrogen peroxide. Free Radic Biol Med. 2007;42:1704\u201314.","journal-title":"Free Radic Biol Med"},{"key":"903_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75:50\u201383.","journal-title":"Microbiol Mol Biol Rev"},{"key":"903_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","volume":"79","author":"C Widmann","year":"1999","unstructured":"Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79:143\u201380.","journal-title":"Physiol Rev"},{"key":"903_CR52","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/nar\/gkp054","volume":"37","author":"S Wang","year":"2009","unstructured":"Wang S, Gong Z, Chen R, Liu Y, Li A, Li G, et al. JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks. Nucleic Acids Res. 2009;37:1936\u201350.","journal-title":"Nucleic Acids Res"},{"key":"903_CR53","doi-asserted-by":"publisher","first-page":"e34154","DOI":"10.1371\/journal.pone.0034154","volume":"7","author":"Z Gong","year":"2012","unstructured":"Gong Z, Shi Y, Zhu Z, Li X, Ye Y, Zhang J, et al. JWA deficiency suppresses dimethylbenz[a]anthracene-phorbol ester induced skin papillomas via inactivation of MAPK pathway in mice. PLoS One. 2012;7:e34154.","journal-title":"PLoS One"},{"key":"903_CR54","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3892\/ol.2014.2329","volume":"8","author":"YY Wu","year":"2014","unstructured":"Wu YY, Ma TL, Ge ZJ, Lin J, Ding WL, Feng JK, et al. JWA gene regulates PANC-1 pancreatic cancer cell behaviors through MEK-ERK1\/2 of the MAPK signaling pathway. Oncol Lett. 2014;8:1859\u201363.","journal-title":"Oncol Lett"},{"key":"903_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41420-022-00992-9","volume":"8","author":"Z Zhai","year":"2022","unstructured":"Zhai Z, Ren Y, Shu C, Chen D, Liu X, Liang Y, et al. JAC1 targets YY1 mediated JWA\/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC. Cell Death Discov. 2022;8:169.","journal-title":"Cell Death Discov"},{"key":"903_CR56","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.3892\/mmr.2015.3188","volume":"11","author":"X Chen","year":"2015","unstructured":"Chen X, Feng J, Ge Z, Chen H, Ding W, Zhu W, et al. Effects of the JWA gene in the regulation of human breast cancer cells. Mol Med Rep. 2015;11:3848\u201353.","journal-title":"Mol Med Rep"},{"key":"903_CR57","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cell.2014.03.006","volume":"157","author":"N Gagliani","year":"2014","unstructured":"Gagliani N, Hu B, Huber S, Elinav E, Flavell RA. The fire within: microbes inflame tumors. Cell. 2014;157:776\u201383.","journal-title":"Cell"},{"key":"903_CR58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12035-014-9010-4","volume":"53","author":"S Sha","year":"2016","unstructured":"Sha S, Xu J, Lu ZH, Hong J, Qu WJ, Zhou JW, et al. Lack of JWA enhances neurogenesis and long-term potentiation in hippocampal dentate gyrus leading to spatial cognitive potentiation. Mol Neurobiol. 2016;53:355\u201368.","journal-title":"Mol Neurobiol"},{"key":"903_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0381-8","volume":"9","author":"R Wang","year":"2018","unstructured":"Wang R, Zhao X, Xu J, Wen Y, Li A, Lu M, et al. Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice. Cell Death Dis. 2018;9:352.","journal-title":"Cell Death Dis"},{"key":"903_CR60","first-page":"205","volume":"24","author":"YQ Xu","year":"2006","unstructured":"Xu YQ, Li AP, Chen R, Zhou JW. The role of JWA in N-methyl-N\u2019-nitro-N-nitrosoguanidine induced human bronchial epithelial cell apoptosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006;24:205\u20138.","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"903_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.taap.2008.01.041","volume":"230","author":"J Zhou","year":"2008","unstructured":"Zhou J, Ye J, Zhao X, Li A, Zhou J. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol Appl Pharm. 2008;230:33\u201340.","journal-title":"Toxicol Appl Pharm"},{"key":"903_CR62","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10495-011-0637-6","volume":"16","author":"L Shen","year":"2011","unstructured":"Shen L, Xu W, Li A, Ye J, Zhou J. JWA enhances As2O3-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells. Apoptosis. 2011;16:1177\u201393.","journal-title":"Apoptosis"},{"key":"903_CR63","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/15287390701290212","volume":"70","author":"XJ Cao","year":"2007","unstructured":"Cao XJ, Chen R, Li AP, Zhou JW. JWA gene is involved in cadmium-induced growth inhibition and apoptosis in HEK-293T cells. J Toxicol Environ Health A. 2007;70:931\u20137.","journal-title":"J Toxicol Environ Health A"},{"key":"903_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04568-4","volume":"13","author":"JY Kim","year":"2022","unstructured":"Kim JY, Bahar E, Lee JY, Chang S, Kim SH, Park EY, et al. ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma. Cell Death Dis. 2022;13:239.","journal-title":"Cell Death Dis"},{"key":"903_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.517","volume":"5","author":"W Xu","year":"2014","unstructured":"Xu W, Chen Q, Wang Q, Sun Y, Wang S, Li A, et al. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. Cell Death Dis. 2014;5:e1551.","journal-title":"Cell Death Dis"},{"key":"903_CR66","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbadis.2018.02.013","volume":"1864","author":"D Qiu","year":"2018","unstructured":"Qiu D, Wang Q, Wang Z, Chen J, Yan D, Zhou Y, et al. RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1552\u201361.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"903_CR67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbrc.2019.10.184","volume":"521","author":"F Chen","year":"2020","unstructured":"Chen F, Pei S, Wang X, Zhu Q, Gou S. Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance. Biochem Biophys Res Commun. 2020;521:753\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"903_CR68","first-page":"94","volume":"75","author":"X Wang","year":"2020","unstructured":"Wang X, Li L, Pei S, Zhu Q, Chen F. Disruption of SSBs repair to combat platinum resistance via the JWA-targeted Pt(IV) prodrug conjugated with a wogonin derivative. Pharmazie. 2020;75:94\u2013101.","journal-title":"Pharmazie"},{"key":"903_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"903_CR70","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2013.06.028","volume":"345","author":"I Rusyn","year":"2014","unstructured":"Rusyn I, Lemon SM. Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett. 2014;345:210\u20135.","journal-title":"Cancer Lett"},{"key":"903_CR71","unstructured":"Wilson GH, Z; Qiao, L Characterization of ARL6IP5 in hepatitis C induced liver cancer. Australian Gastroenterology Week; Adelaide 2012."},{"key":"903_CR72","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0168-8278(00)80013-6","volume":"33","author":"Y Sumida","year":"2000","unstructured":"Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol. 2000;33:616\u201322.","journal-title":"J Hepatol"},{"key":"903_CR73","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0891-5849(96)00044-5","volume":"21","author":"N De Maria","year":"1996","unstructured":"De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med. 1996;21:291\u20135.","journal-title":"Free Radic Biol Med"},{"key":"903_CR74","first-page":"3171","volume":"54","author":"R Shimoda","year":"1994","unstructured":"Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 1994;54:3171\u20132.","journal-title":"Cancer Res"},{"key":"903_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481\u20135.","journal-title":"Nature"},{"key":"903_CR76","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1158\/1078-0432.CCR-11-2863","volume":"18","author":"S Wang","year":"2012","unstructured":"Wang S, Wu X, Chen Y, Zhang J, Ding J, Zhou Y, et al. Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. Clin Cancer Res. 2012;18:2987\u201396.","journal-title":"Clin Cancer Res"},{"key":"903_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/v12030353","volume":"12","author":"CN Wose Kinge","year":"2020","unstructured":"Wose Kinge CN, Bhoola NH, Kramvis A. In vitro systems for studying different genotypes\/sub-genotypes of hepatitis B virus: strengths and limitations. Viruses. 2020;12:353.","journal-title":"Viruses"},{"key":"903_CR78","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/cncr.32789","volume":"126","author":"Z Liu","year":"2020","unstructured":"Liu Z, Suo C, Mao X, Jiang Y, Jin L, Zhang T, et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017. Cancer. 2020;126:2267\u201378.","journal-title":"Cancer"},{"key":"903_CR79","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019;394:1451\u201366.","journal-title":"Lancet"},{"key":"903_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00261-017-1209-1","volume":"43","author":"A Tang","year":"2018","unstructured":"Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radio. 2018;43:13\u201325.","journal-title":"Abdom Radio"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00903-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T22:03:31Z","timestamp":1753049011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00903-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00903-x","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The acknowledgment section has been amended: The study was supported by the grants from the following funders: NHMRC(APP1047417); National Natural Science Foundation of China (32460305); Natural Science Foundation of Gansu Province of China (22JR5RA902). We appreciate Prof. Jacob George from The University of Sydney and Prof. Yongning Zhou from Lanzhou University for their supervision.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}